Prognostic and predictive values of high-resolution molecular DNA markers in non-small cell lung cancers (NSCLC) of IFCT-00-02 trial (Phase III study comparing a preoperative and a perioperative chemotherapy with two different chemotherapy regimens in resectable NSCLC)